Previous Close | 24.36 |
Open | 24.46 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 24.37 - 24.82 |
52 Week Range | 21.53 - 33.09 |
Volume | |
Avg. Volume | 944,861 |
Market Cap | 10.842B |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | 41.33 |
EPS (TTM) | 0.60 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.75 (3.02%) |
Ex-Dividend Date | Apr 01, 2024 |
1y Target Est | 31.50 |
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -